Elkfork Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$498K Hold
6,490
0.01% 576
2019
Q2
$558K Hold
6,490
0.01% 547
2019
Q1
$383K Hold
6,490
0.01% 633
2018
Q4
$342K Hold
6,490
0.01% 625
2018
Q3
$360K Buy
6,490
+330
+5% +$17K 0.01% 696
2018
Q2
$290K Hold
6,160
0.01% 687
2018
Q1
$223K Buy
6,160
+1,100
+22% +$38.7K 0.01% 756
2017
Q4
$184K Buy
5,060
+880
+21% +$31.9K 0.01% 808
2017
Q3
$160K Buy
4,180
+924
+28% +$38.7K ﹤0.01% 787
2017
Q2
$135K Buy
3,256
+1,672
+106% +$63.5K ﹤0.01% 790
2017
Q1
$56K Buy
1,584
+132
+9% +$4.18K ﹤0.01% 875
2016
Q4
$45K Buy
+1,452
New +$44.9K ﹤0.01% 892

Other funds holding RGEN

Elkfork Partners's RGEN Position: Q3 2019 in Review

Elkfork Partners held its Repligen (RGEN) position steady in Q3 2019 at 6,490 shares worth $498K. The position accounts for 0.01% of the portfolio, ranked #576.

Elkfork Partners first reported a position in RGEN in Q4 2016 and has held it in 12 quarters since. The position peaked at $558K in Q2 2019. 303 funds tracked by Wall St. Rank hold RGEN as of Q3 2019.

  • Elkfork Partners held 6,490 shares of Repligen worth $498K as of Q3 2019.
  • Elkfork Partners left its Repligen share count unchanged in Q3 2019.
  • Repligen made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #576 holding.
  • Elkfork Partners first reported a position in Repligen in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Repligen position peaked at $558K in Q2 2019.
  • 303 funds tracked by Wall St. Rank held Repligen as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.